How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies
April 24, 2024In the dynamic laboratory diagnostics industry, staying ahead means having smart strategies in place. Market research is the secret ingredient…4 Key Components to a Winning Go-To-Market Strategy
April 24, 2024Crafting a successful go-to-market (GTM) strategy in the laboratory diagnostic industry requires strategic planning and meticulous execution. It's more than…Cell and Gene Therapy Funding Totaled $40 Billion in 2022, Growth Projected
June 15, 2023Cell and gene therapy is attracting much attention these days and for good reason. For one, there has been a…It’s 2023: Where is the At-Home IVD Testing Market Now?
June 13, 2023The Home IVD testing market is not new, but it had primarily been limited to glucose and pregnancy testing. COVID-19 testing has opened the door…New Kalorama Report Pegs Clinical Lab Services Market at 168BN
May 18, 2023The global market for clinical laboratory services grew to an estimated $168.3 billion during 2022. This is according to Kalorama's latest report on clinical…Despite Declines, COVID-19 Still a Large IVD Market
May 1, 2023When a market declines in momentum, it's easy to forget that it still contributes to the overall market. This is…Six Trends to Watch in POC-IVD
April 19, 2023Point of care IVD sales reached 45 billion dollars in 2022. This includes instruments - permanent and disposable, and associated…Hematology Grows, Driven by Decentralization
April 7, 2023The global market for hematology testing, inclusive of analyzers/instruments and reagents, is valued at $5,655 million in 2022. This includes…Still Room to Grow in Infectious Disease IVD
March 3, 2023Per Kalorama Information's World Infectious Disease report: Opportunities for infectious disease testing products vary widely between the developed and developing countries, according to…Growth in Molecular Diagnostics, Beyond COVID-19
February 6, 2023COVID-19 is not over, but test sales are clearly on the decline, and IVD companies for the most part have…